RT Journal Article SR Electronic T1 National Institute for Health Research Health Informatics Collaborative (NIHR HIC): Development of a Pipeline to Collate Electronic Clinical Data for Viral Hepatitis Research JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2019.12.16.19015065 DO 10.1101/2019.12.16.19015065 A1 David A Smith A1 Tingyan Wang A1 Oliver Freeman A1 Charles Crichton A1 Hizni Salih A1 Philippa C Matthews A1 Jim Davies A1 Kinga A Várnai A1 Kerrie Woods A1 Christopher R. Jones A1 Ben Glampson A1 Abdulrahim Mulla A1 Luca Mercuri A1 A. Torm Shaw A1 Lydia Drumright A1 Luis Romão A1 David Ramlakan A1 Finola Higgins A1 Alistair Weir A1 Eleni Nastouli A1 Kosh Agarwal A1 William Gelson A1 Graham S. Cooke A1 Eleanor Barnes YR 2020 UL http://medrxiv.org/content/early/2020/04/24/2019.12.16.19015065.abstract AB Objective The National Institute of Health Research (NIHR) Health Informatics Collaborative (HIC) is a programme of infrastructure development across NIHR Biomedical Research Centres (BRCs). The aim of the NIHR HIC is to improve the quality and availability of routinely-collected data for collaborative, cross-centre research. This is demonstrated through research collaborations in selected therapeutic areas, one of which is viral hepatitis.Design The collaboration in viral hepatitis identified a rich set of data points, including information on clinical assessment, antiviral treatment, laboratory test results, and health outcomes. Clinical data from different centres was standardised and combined to produce a research-ready dataset; this was used to generate insights regarding disease prevalence and treatment response.Results A comprehensive database has been developed for potential viral hepatitis research interests, with a corresponding data dictionary for researchers across the centres. An initial cohort of 960 patients with chronic hepatitis B infections and 950 patients with chronic hepatitis C infections has been collected.Conclusion For the first time, large prospective cohorts are being formed within NHS secondary care services that will allow research questions to be rapidly addressed using real world data. Interactions with industry partners will help to shape future research and will inform patient-stratified clinical practice. An emphasis on NHS-wide systems interoperability, and the increased utilisation of structured data solutions for electronic patient records, is improving access to data for research, service improvement and the reduction of clinical data gaps.What is already known?Electronic Patient Records in NHS trusts contain a wealth of routinely-collected clinical data useful for translational research. However, this data is not easily accessible to the individual NHS Trust or researchers.There is a shortage of detailed clinical data available for patients with viral hepatitis in the UK, in particular for patients infected with the hepatitis B or E viruses.What does this paper add?We present a comprehensive methodology that has been proposed, implemented and validated by the NIHR HIC for the development of a new data collection and management pipeline.We show that routinely-collected clinical data from patients with hepatitis C, B and E infection can be collated, integrated and made available to researchers automatically from 5 large NHS trusts.We describe the initial data collected from 906 hepatitis B infected patients and 1404 hepatitis C infected patients.Competing Interest StatementDr. Drumright reports grants from National Institute for Health Research, during the conduct of the study. Dr. Agarwal reports personal fees from Vir, personal fees from Gilead, personal fees from Springbank, personal fees from Roche, personal fees from janssen, personal fees from biotest, personal fees from Aligos, personal fees from Arbutus, personal fees from Assembly, personal fees from Shinoigi, grants from MSD, outside the submitted work. Dr. Cooke reports personal fees from Gilead Inc and MSD outside the submitted work. Dr. Glampson reports other from Imperial NIHR BRC, during the conduct of the study. A. Torm Shaw reports grants from NIHR Health Informatics Collaborative (HIC), other from NIHR Biomedical Research Centres (BRC), during the conduct of the study. Dr. Nastouli reports grants from ViiV healthcare, grants from GSK, grants from Gilead, outside the submitted work.Funding StatementThis work has been facilitated by infrastructure development supported by NIHR Biomedical Research Centres (BRC) at Cambridge, Guy’s and St Thomas’, Imperial, Oxford and UCLH and funded by the NIHR Health Informatics Collaborative (HIC). GC is an NIHR Research Professor, EB is an NIHR Senior Investigator. PCM is funded by the Wellcome Trust and holds an NIHR Senior Fellowship award.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available to researchers from on request https://hic.nihr.ac.uk/